What is the next step in management for a 74‑year‑old patient with chest pain radiating to the back, now pain‑free, and electrocardiogram showing ST‑segment depression in leads II, aVL, V3‑V6?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Coronary Angiography Within 24 Hours

This 74-year-old patient with chest pain radiating to the back, now pain-free, and ST-segment depression in multiple leads (II, aVL, V3-V6) requires urgent coronary angiography within 24 hours along with immediate dual antiplatelet therapy and anticoagulation. 1

Risk Stratification

This patient meets high-risk criteria for non-ST-elevation acute coronary syndrome (NSTE-ACS):

  • ST-segment depression in multiple leads (6 leads: II, aVL, V3-V6) indicates significant myocardial ischemia and is associated with 1-year mortality/MI risk of approximately 16% 2
  • Chest pain radiating to the back raises concern for aortic dissection as a critical differential diagnosis that must be excluded 1
  • Age 74 years is an independent risk factor for adverse outcomes 1
  • ST-segment depression ≥0.5 mm in ≥3 leads strongly suggests significant coronary artery disease 2

The European Society of Cardiology classifies this presentation as requiring an early invasive strategy within 24 hours based on dynamic ST-segment changes suggesting ongoing ischemia 1

Immediate Management (First 10 Minutes)

Exclude Life-Threatening Mimics

  • Obtain focused history for sudden tearing/ripping back pain, pulse differential, or blood pressure differential between arms to exclude aortic dissection before administering antithrombotic therapy 1
  • Perform bedside echocardiography if available to assess for regional wall motion abnormalities, pericardial effusion, or aortic dissection 1

Initial Medical Therapy

Antiplatelet therapy:

  • Aspirin 150-300 mg oral loading dose (or 75-250 mg IV if unable to take oral), followed by 75-100 mg daily 1, 3
  • Ticagrelor 180 mg loading dose, then 90 mg twice daily (preferred over clopidogrel for moderate-to-high risk patients) 1, 3

Anticoagulation:

  • Unfractionated heparin or low-molecular-weight heparin (enoxaparin) should be initiated immediately 1, 3

Anti-ischemic therapy:

  • Beta-blocker (e.g., metoprolol 5 mg IV every 2 minutes × 3 doses if hemodynamically stable, then oral metoprolol 50 mg every 6 hours) to reduce myocardial oxygen demand with target heart rate 50-60 bpm 1, 4
  • Sublingual or IV nitroglycerin for ongoing chest discomfort; IV route is more effective for symptom relief and regression of ST depression 3
  • Morphine for pain relief if nitroglycerin is insufficient 1

Diagnostic Workup

Serial Cardiac Biomarkers

  • Measure high-sensitivity cardiac troponin immediately and repeat at 3 hours and 6-12 hours 1, 2
  • Elevated troponin identifies patients at high risk for progression to MI or death who benefit most from intensive antiplatelet therapy and early invasive strategy 1, 3

Continuous Monitoring

  • Continuous 12-lead ECG monitoring identifies ischemic changes in an additional 16% of patients compared with standard serial ECGs 2
  • Monitor for recurrent chest pain, during which an ECG should be recorded immediately 1
  • Monitor for hemodynamic instability (hypotension, pulmonary rales) which would upgrade to immediate invasive strategy (<2 hours) 1

Additional Laboratory Tests

  • Complete blood count (hemoglobin to detect anemia) 1
  • Serum creatinine for renal function assessment 1
  • Electrolytes (especially potassium, as hypokalemia can cause ST-T changes) 2
  • Lipid profile in the early phase of admission 1

Timing of Invasive Strategy

Coronary angiography within 24 hours is indicated based on: 1

  • Dynamic ST-segment changes suggesting ongoing ischemia
  • ST-segment depression in multiple leads (6 leads)
  • Elderly patient with likely elevated troponin

Upgrade to immediate invasive strategy (<2 hours) if any of the following develop: 1

  • Hemodynamic instability or cardiogenic shock
  • Recurrent or refractory chest pain despite medical treatment
  • Life-threatening arrhythmias
  • Heart failure clearly related to NSTE-ACS

Critical Pitfalls to Avoid

  • Do not dismiss the back pain component – aortic dissection must be excluded before administering antithrombotic therapy, as this is a life-threatening contraindication 1
  • Do not delay dual antiplatelet therapy – both aspirin and a P2Y12 inhibitor should be given immediately unless aortic dissection is suspected 3
  • Do not use fibrinolysis – it is contraindicated and harmful in NSTE-ACS 3
  • Do not attribute ST depression to age or hypertension alone – this ECG pattern in the setting of chest pain represents acute coronary syndrome until proven otherwise 2
  • Do not rely on a single troponin measurement – serial assessments are required to reliably exclude myocardial injury 2

Additional Considerations

  • Check for posterior MI – obtain posterior leads (V7-V9) as approximately 4% of acute MIs present with ST elevation only in posterior leads, which may manifest as ST depression in anterior leads 2
  • Assess for contraindications to beta-blockers – overt heart failure, hemodynamic instability, or severe bradycardia 1
  • Avoid nitrates if phosphodiesterase-5 inhibitor taken within 24 hours (sildenafil/vardenafil) or 48 hours (tadalafil) due to severe hypotension risk 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Summary for Asymptomatic ST‑T Changes and ST‑Depression on Routine ECG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Postoperative Non-ST-Elevation Myocardial Infarction (NSTEMI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.